Corporate information

Official name
InterMune Inc
Registration country

Company type

Biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.

Funding rounds

Acquisition USD 8,300,000,000


USD 8,300,000,000 ( ) at USD 8,300,000,000 pre-money valuation

Profile Country Notes
Roche Holding AG USD 8,300,000,000 (USD 8,300,000,000) Initial investment. Led the round.

Profile Country
Alta Partners LP Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies.

Profile Country
BayStar Capital

Profile Country
Charter Venture Capital (Charter Ventures), (Charter Life Sciences Venture Capital) Venture capital firm

Profile Country
Connetics Corp

Profile Country
Genentech Inc Discovery, development, commercialization and manufacturing of biotherapeutics by using human genetic information

Profile Country
J&W Seligman & Co

Profile Country
Moore Capital Management LP (MCM)

Profile Country
Sanderling Ventures

Profile Country
Sofinnova Ventures Inc

Profile Country
Vector Fund Management

Profile Country
Vivo Ventures LLC


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials